Search for: "Application of US in Order Authorizing, Etc."
Results 101 - 120
of 2,751
Sort by Relevance
|
Sort by Date
23 Nov 2023, 1:42 am
II) Novozymes HC decision: A brief overview 1) Background of the Patent and invention at issue In its decision dated September 20, 2023, the Court, setting aside the Indian Patent Office (IPO)’s order partly, pronounced that the substantive provision in S. 3(d) applies to biochemical substances in principle but Explanation to S. 3(d) becomes inapplicable to the claimed invention in Indian patent application 5326/CHENP/2008 – pertaining to the variants of phytase, i.e.… [read post]
22 Nov 2023, 6:44 am
” It’s not entirely clear what the column’s author, Geoffrey A. [read post]
18 Nov 2023, 10:05 am
[xviii] In a first phase, the investigating authorities are under an obligation to examine the factors provided by Article 15.4 ASCM or Article 3.4 of the ADA, as applicable, so as to determine the situation of the domestic industry. [read post]
18 Nov 2023, 10:05 am
[xviii] In a first phase, the investigating authorities are under an obligation to examine the factors provided by Article 15.4 ASCM or Article 3.4 of the ADA, as applicable, so as to determine the situation of the domestic industry. [read post]
8 Nov 2023, 3:09 pm
In order to take advantage of Section 245k, the beneficiary must be arriving on a valid nonimmigrant status, such as H, L, E, TN…etc. [read post]
8 Nov 2023, 8:24 am
Decision-making responsibilities Regarding Colorado’s child custody laws, the allocation of parental authority is the first component. [read post]
8 Nov 2023, 5:31 am
Boston, Little, Brown and Company; [etc., etc.] 1853. [read post]
6 Nov 2023, 2:37 pm
When crediting original work, re-users can use the format “Title” by Author. [read post]
2 Nov 2023, 5:23 am
More from our authors: Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 Genuine Use of Trademarks, Second Edition by Eléonore Gaspar€ 190 [read post]
25 Oct 2023, 10:25 am
Bertoldi agrees that home health treatment is reasonable and necessary, the parties should follow the procedures in section 4610 etc. to determine whether defendant should authorize and pay for such treatment. [read post]
23 Oct 2023, 7:39 am
· SB 813 makes additional changes to medical marijuana laws regarding application and licensing fees and authorizes the Oklahoma Medical Marijuana Authority to operate a compliance lab. [read post]
19 Oct 2023, 2:01 pm
This meant not only that the judiciary had authority of [read post]
19 Oct 2023, 8:59 am
On 1/20/2022, applicant’s treating physician requested authorization for Vraylar 4.5mg #30. [read post]
17 Oct 2023, 11:38 am
The Consolidated Appropriation Act 2021 authorized the extension of the WOTC until December 31, 2025. [read post]
17 Oct 2023, 5:15 am
Customary international law further regulates the conduct of hostilities by all belligerents, and provides protections for civilians and civilian objects (such as medical facilities, schools, etc. that are not in military use). [read post]
13 Oct 2023, 3:38 am
The requirements for the grant of a preliminary injunction: urgency and irreparable harm Article 62(1) UPC Agreement [here] grants the UPC the authority to order injunctions “on a provisional basis” (hereafter PIs). [read post]
11 Oct 2023, 10:19 pm
Prompted by several of the working group’s additional recommendations–and numerous, alarming press reports of water users diverting water without a legitimate water right, defying State Water Board drought response orders requiring curtailment of private water diversions, etc. [read post]
11 Oct 2023, 4:09 pm
Offerors must disclose all pertinent information in their bid, as laid out in paragraph (e), including the name of the product or service, the name of the covered article or source subject to a FASCSA order, the names of any applicable vendors or brands, model numbers, etc. [read post]
10 Oct 2023, 7:42 am
Which brings us to a quick review of applicable regulatory takings law. [read post]
6 Oct 2023, 12:48 pm
A few observations are in order: First, FDA’s timeline is, to put it mildly, wildly ambitious. [read post]
